Sorrento Therapeutics Inc Equity-NMS: SRNE

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Previous close :$0.0005
1Y :-99.17%
5Y :-99.99%

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Sorrento Therapeutics Inc $0.0005 0% - NaN

Frequently Asked Questions

What is the share price of Sorrento Therapeutics Inc today?

Sorrento Therapeutics Inc (SRNE) share price as of January 21, 2025, is $0.0005. If you are investing from India, you can always check the valuation in the INR before investing.

About Sorrento Therapeutics Inc

Sorrento Therapeutics, Inc. is a clinical-stage, antibody-centric, biopharmaceutical company developing therapies to treat cancers and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. Sorrento Therapeutics segment is organized around Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate cancer therapeutics. The Scilex segment is largely organized around its non-opioid pain management operations. The Company’s immuno-oncology platforms, including key assets such as fully human antibodies (G-MAB library), clinical- stage immuno-cellular therapies (CAR-T, DAR-T), antibody-drug conjugates (ADCs) and clinical-stage oncolytic virus (Seprehvir). The Company is also developing potential antiviral therapies and vaccines against coronaviruses, including Abivertinib, COVI-AMG, COVISHIELD, COVI-MSC and COVIDROPS, and diagnostic test solutions, including COVITRACK and COVISTIX.